Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence

British Journal of Pharmacology

Volumn 132, Issue 7, 2001, Pages 1493-1500

  Barrett, Terrance D ^a   Hennan, James K ^a   Fischbach, Peter S ^a   O'Neill, Brian P ^a   Driscoll, Edward M ^a   Lucchesi, Benedict R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Class III; Dofetilide; Proarrhythmia; QT prolongation; Tedisamil; Torsades de pointes

Indexed keywords

DOFETILIDE; POTASSIUM; TEDISAMIL;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; HEART PROARRHYTHMIA; HEART RATE; ISOLATED HEART; MALE; NONHUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; QT INTERVAL; RABBIT; TORSADE DES POINTES;

EID: 0035074005     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703967     Document Type: Article

References (34)

1. The M cell: Its contribution to the ECG and to normal and abnormal electrical function of the heart
2. Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium channel-blocking agent
3. + channel blocker
4. Differential inhibition by tedisamil (KC 8857) and glibenclamide of the responses to cromakalim and minoxidil sulfate in rat isolated aorta
5. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: Experimental profile of BRL-32872
6. Comparative assessment of ibutilide, D-sotalol, clofilium, E-4031, and UK-68,798 in a rabbit model of proarrhythmia
7. Effects of tedisamil (KC-8857) on cardiac electrophysiology an ventricular fibrillation in the rabbit isolated heart model
8. Evidence-based analysis of amiodarone efficacy and safety
9. [3H]Dofetilide binding to cardiac myocytes: Modulation by extracellular potassium
10. + currents in mammalian cardiac and glial cells
11. + current in rat ventricular myocytes
12. A randomiszed, double-blind, placebo-controled, dose-ranging study of dofetilide in patients with inducible sustained ventricular tachyarrhythmias
13. Experimental models of torsades de pointes
14. Comparative effects of glibenclamide, tedisamil, dofetilide, E-4031, and BRL-32872 on protein kinase A-activated chloride current in guinea pig ventricular myocytes
15. Tedisamil in chronic canine atrial flutter
16. Antianginal and anti-ischaemic efficacy of tedisamil, a potassium channel blocker
17. Antifibrillatory efficacy of long-term tedisamil administered in a postinfarcted canine model of ischemic ventricular fibrillation
18. Tedisamil attenuates ventricular fibrillation in a conscious canine model of sudden cardiac death
19. Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery
20. Class III antiarrhyhtmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence
21. The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis
22. Clofilium in the isolated perfused rabbit heart: A new model to study proarrhythmia induced by class III antiarrhythmic drugs
23. Safety and efficacy of sotalol in patients with drug refractory sustained ventricular tachyarrhythmias
24. Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter
25. The cellular electrophysiological effects of tedisamil in human atrial and ventricular fibres
26. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment
27. to blocker increases coronary flow independent of effects on heart rate, QT interval and ischaemia-induced ventricular fibrillation in rat
28. + current. Differential sensitivity to block by class III antiarrhythmic agents
29. Acute hemodynamic effects of intravenous ibutilide in patients with without reduced left ventricular function
30. Dofetilide in patients with congestive heart failure and left ventricular dysfunction
31. Influence of tedisamil on the initiation and maintenance of ventricular fibrillation: Chemical defibrillation by Ito blockade?
32. Cardiac electrophysiological and antiarrhythmic actions of tedisamil
33. Kr. Implications for torsade de pointes and reverse use-dependence
34. Electrophysiological features of torsades de pointes: Insight from a new isolated rabbit heart model